Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic

Renin-angiotensin-aldosterone system inhibitors and the COVID-19 epidemic

Bibliographic Details
Main Authors:	José Silva-Cardoso, Emilia Moreira
Format:	Article
Language:	English
Published:	Elsevier 2022-10-01
Series:	Revista Portuguesa de Cardiologia
Online Access:	http://www.sciencedirect.com/science/article/pii/S0870255122003614

Similar Items

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01)

Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
by: Andre Feldman, et al.
Published: (2020-11-01)

The renin angiotensin aldosterone system and COVID-19
by: Hadeel A. Alsufyani, et al.
Published: (2020-08-01)

Renin-Angiotensin-Aldosterone System Inhibitors in COVID-19: A Review
by: Filipe Ferrari, et al.
Published: (2021-04-01)

Renin‐Angiotensin Aldosterone System Inhibitors in Primary Prevention and COVID‐19
by: Jordan Loader, et al.
Published: (2021-08-01)

Renin-angiotensin-aldosterone system in patients with COVID-19
by: Giacomo Fedi, et al.
Published: (2020-12-01)

Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19
by: Angela Madalina Lazar
Published: (2021-07-01)

Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.
by: Jungchan Park, et al.
Published: (2021-01-01)

Impact of the withdrawal of renin-angiotensin-aldosterone inhibitors on mortality in COVID-19 patients
by: Juan Caro-Codón, et al.
Published: (2022-10-01)

COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
by: Fatemeh Babajani, et al.
Published: (2021-12-01)

The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity
by: Wan-Hui Liao, et al.
Published: (2020-12-01)

Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
by: Jorge Gonçalves, et al.
Published: (2023-04-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

How to potentialize the effect of renin-angiotensin-aldosterone system inhibitors?
by: D.D. Ivanov
Published: (2021-09-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-05-01)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
by: Niki Katsiki, et al.
Published: (2020-04-01)

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with COVID-19: General Considerations and Clinical Implications
by: Neiberg de Alcantara Lima, et al.
Published: (2020-06-01)

Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
by: Si-Hyuck Kang, et al.
Published: (2021-06-01)

Novel Class of Central Renin Angiotensin Aldosterone System Inhibitor: Firibastat
Published: (2022-05-01)

Beyond the circulating renin angiotensin aldosterone system
by: Walmor eDe Mello
Published: (2014-07-01)

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19
by: Annamaria Mascolo, et al.
Published: (2021-04-01)

COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system
by: Susanne Rysz, et al.
Published: (2021-04-01)

Is the prognosis of non‐hypertensive, COVID‐19 patients treated with renin–angiotensin–aldosterone system inhibitors more uncertain?
by: Juan José García Martínez, et al.
Published: (2022-11-01)

The renin–angiotensin–aldosterone system: Role in pathogenesis and potential therapeutic target in COVID‐19
by: Cássia L. Braga, et al.
Published: (2020-08-01)

Influence of renin‐angiotensin‐aldosterone system inhibitors on plasma levels of angiotensin‐converting enzyme 2
by: Tobias Zimmermann, et al.
Published: (2021-04-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010-01-01)

Dynamic Changes in the Renin-Angiotensin-Aldosterone System and the Beneficial Effects of Renin-Angiotensin-Aldosterone Inhibitors on Spatial Learning and Memory in a Rat Model of Chronic Cerebral Ischemia
by: Xinwu Huang, et al.
Published: (2017-06-01)

Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic
by: E. V. Sayutina, et al.
Published: (2022-03-01)

The Renin–Angiotensin–Aldosterone System and Coronavirus Disease 2019
by: Eliecer Coto, et al.
Published: (2021-03-01)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
by: Maricica Pacurari, et al.
Published: (2014-01-01)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
by: P. Stiefel, et al.
Published: (2011-01-01)

Updates on the Renin–Angiotensin–Aldosterone System and the Cardiovascular Continuum
by: Dana Pop, et al.
Published: (2024-07-01)

The Retinal Renin-Angiotensin-Aldosterone System: Implications for Glaucoma
by: Kazuyuki Hirooka, et al.
Published: (2022-03-01)

What is the association of renin–angiotensin–aldosterone system inhibitors with COVID-19 outcomes: retrospective study of racially diverse patients?
by: Andrea L Cherrington, et al.
Published: (2022-04-01)

Do renin-angiotensin-aldosteron system inhibitors protect kidneys during vancomycin administration?
by: T. Kitazawa, et al.
Published: (2014-04-01)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
by: Namrata Singhania, et al.
Published: (2020-11-01)

Fallacies in medical practice: Renin-angiotensin-aldosterone system inhibition and COVID-19 as a Paradigm
by: Filippos Triposkiadis, et al.
Published: (2021-05-01)